PLPP5
Summary:
Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
---|---|---|---|---|---|
phospholipid phosphatase 5 | MIM:610626 | Ensembl:ENSG00000147535 | HGNC:HGNC:25026 | PA142671154 | 8p11.23 |
GO terms in PLPP5
Term Type | Evidence Type | GO Term ID | GO Des. |
---|---|---|---|
MF | IBA | GO:0008195 | phosphatidate phosphatase activity |
MF | IDA | GO:0008195 | phosphatidate phosphatase activity |
MF | IBA | GO:0016791 | phosphatase activity |
CC | TAS | GO:0005737 | cytoplasm |
CC | TAS | GO:0005886 | plasma membrane |
CC | IBA | GO:0005887 | integral component of plasma membrane |
BP | IBA | GO:0006644 | phospholipid metabolic process |
BP | IBA | GO:0007165 | signal transduction |
BP | IBA | GO:0046839 | phospholipid dephosphorylation |
BP | IDA | GO:0046839 | phospholipid dephosphorylation |
Gene expression in normal tissue: PLPP5
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in PLPP5
Database | Pathway ID | Pathway Des. |
---|---|---|
reactome | R-HSA-168249 | Innate Immune System |
reactome | R-HSA-168256 | Immune System |
reactome | R-HSA-2029480 | Fcgamma receptor (FCGR) dependent phagocytosis |
reactome | R-HSA-2029485 | Role of phospholipids in phagocytosis |
kegg | hsa00561 | Glycerolipid metabolism - Homo sapiens (human) |
kegg | hsa00564 | Glycerophospholipid metabolism - Homo sapiens (human) |
Gene-Drug: Aster Plot
Drug ID | Drug Name | Model Num. |
---|---|---|
iGMDRD318 | PAC-1 | 6 |
iGMDRD885 | Compound 110 | 3 |
iGMDRD781 | Sirolimus | 6 |
iGMDRD267 | Oligomycin A | 3 |
iGMDRD427 | ABT737 | 3 |
iGMDRD889 | Compound 7d-cis | 3 |
iGMDRD420 | Leucascandrolide A | 6 |
iGMDRD486 | Tosedostat | 3 |
iGMDRD435 | BI-2536 | 6 |
iGMDRD300 | Tozasertib | 3 |
iGMDRD886 | Compound 1541A | 3 |
iGMDRD505 | Pevonedistat | 3 |
iGMDRD506 | Fedratinib | 9 |
Gene in drug-gene network: Network Plot
Gene-drug targets distribution
Gene Structure: PDB
Models in PLPP5